Pomáháme lékům pomáhat

Lékům vdechujeme reálný život

 

Publikace

Postery na konferencích

2023

The Life with Myasthenia Gravis: Socioeconomic Impact of the Disease on Patients in the Czech Republic

Danielisova M, Mlcoch T, Volfova G, Bruhova H, Malachova M, Horakova M, Dolezal H, Chlad R, Dolezal T. ISPOR Europe 2023, Copenhagen, Denmark.

Cost-utility analysis of 15-valent pneumococcal conjugate vaccine in the immunization of adults over 65 years of age in the Czech Republic

Volfova G, Mlcoch T, Uherek S, Lamblova K, Zadak J, Vaverkova E, Dolezal T. ISPOR Europe 2023, Copenhagen, Denmark.

Atoderma: Clinical and economic burden of moderate to severe atopic dermatitis in the Czech Republic

Chadimova K, Lamblova K, Blazkova T, Doleckova K, Berezna J, Tuzil J, Turkova B, Mlcoch T, Dolezal H, Dolezal T. ISPOR Europe 2023, Copenhagen, Denmark.

The Burden of Migraine in Czech Republic: Patient, Payer, and Societal Perspective

Doleckova K, Mazalova M, Schimmerova A, Pejrilova D, Blazejovska R, Volfova G, Berezna J, Decker B, Mlcoch T, Dolezal H, Dolezal T. ISPOR Europe 2023, Copenhagen, Denmark.

Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic

Volfova G, Podolska K, Berezna J, Chadimova K, Dolezal H, Dolezal T, Reineltova J, Brectan R, Haberlova J, Mlcoch T. ISPOR Europe 2023, Copenhagen, Denmark.

Apremilast for the treatment of moderate to severe psoriasis: Real world data from the Czech Republic BIOREP Registry

Kojanova M, Fialova J, Cetkovska P, Gkalpakiotis S, Machovcova A, Arenberger P, Stork J, Dolezal T, Turkova B and the BIOREP study group. EADV Symposium, 18-20 May 2023 Seville.

2022

Subclinical Hypothyroidism Influences the Quality of Life During Pregnancy: Results From ThyPreQoL2020

Tuzil J, Pilnackova Filkova B, Torquil W, Jiskra J, Koudelkova M, Novotna E, Dolezal T, Bartakova J. PODIUM PRESENTATION. ISPOR Europe 2022, Vienna, Austria.

Comparative analysis of expenditure on pharmaceuticals in Czechia and Slovakia – how to understand the OECD statistics

Pustalovova A, Szilagyiova P, Dolezal T, Dedik M. ISPOR Europe 2022, Vienna, Austria.

The life with cystic fibrosis: socioeconomic impact of the disease on patients and their caregivers in the Czech Republic

Mlcoch T, Turkova B, Doleckova K, Koznarova B, Zabranska S, Pilnackova B, Decker B, Tuzil J, Blazkova T, Dolezalova H, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

Time in remission as an alternative outcome measure for ankylosing spondylitis: a 14-year prospective study of 900 users of anti-TNF

Tuzil J, Mlcoch T, Zavada J, Svoboda M, Pavelka K, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

Cost-effectiveness analysis of 4% fluorouracil for the treatment of actinic keratosis in the Czech Republic

Blazkova T, Mlcoch T., Ornstova E, Sevec M, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

Patient-reported symptoms are the sole independent predictor of the societal burden associated with inflammatory bowel disease: a cross-sectional study

Decker B, Tuzil T, Lukas M, Cerna K, Bortlik M, Turkova B, Pilnackova B, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension

Ornstova E, Tuzil J, Chadimova K, Mlcoch T, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

Novel approach to decision making for orphan drugs

Decker B, Mlcoch, T, Pustalovova A, Dolezal T. ISPOR Europe 2022, Vienna, Austria.

 

2021

 The health and economic impact of allergen therapy in patients with allergic rhinoconjunctivitis: real-word evidence from the Czech republic

Doležal T, Janickova N, Velackova B, Strosova D, Pilnackova B, Dolezalova H, Allergy Therapeutics (2021)

 

2020

Living with duchenne muscular dystrophy: medical, psychosocial and financial burden

Podolská K, Juříková L, Hájíčková B, Velacková B, Bálintová Z, Staněk J, Haberlová J, Doležal T, Mlčoch T, Rome, Italy (2020).

 

2019

Cost-effectiveness analysis of sucrose octasulfate (urgostart) dressing in the treatment of diabetic foot and venous leg ulcers

Mlcoch T, Bartakova J, Chadimova K,Ornstova E, Hajickova B, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark.

The economic burden of alcohol consumption in the czech republic

Chadimova K, Mlcoch T, Dolejsi D, Hajickova B, Mazalova M, Lamblova K, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark.

Economic burden of atherotrombotic disease in the czech republic

Hajickova B, Mlcoch T, Vydrova J, Zadak J, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark.

Economic impact of type 2 diabetes and diabetes-associated complications: a large claims-based study

Hajickova B, Paris M, Mlcoch T, Ornstova E, Bartakova J, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark. 

Cheap or timely drug? Practical impact of external reference pricing policy in the European Union

Milosic R, Mlcoch T, Paris M, Svitil P, Koubsky T, Dolezal T, Laxton J, Zasukhina E. ISPOR Europe 2019, Copenhagen, Denmark. 

Measuring delays in the availability of new medicines within Europe using a time-to-price indicator

Milosic R, Paris M, Mlcoch T, Svitil P, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark. 

Beyond international pricing index model in the united states – impact to global pricing strategies & access to innovative medicines

Svitil P, Milosic R, Paris M, Mlcoch T, Dolezal T. ISPOR Europe 2019, Copenhagen, Denmark. 

Overall and progression-free survival according to MSKCC score in first-line sunitinib treatment of metastatic renal cell carcinoma (mRCC)

Fínek J, Poprach A, Melichar B, Kopecký J, Zemanová M, Buchler T, Kopečková K, Mlčoch T, Doležal T, Fiala O, ESMO 2019 Congress, Barcelona, Spain

The health and economic impact of allergen therapy in patients with allergic Rhinoconjunctivitis: real-word evidence from the Czech republic

Dolezal T, Janickova N, Strosova D, Filkova B, Jircikova J, Dolezalova H, EAACI 2019, Lisbon, Portugal.

 

2018

Treatment sequences in metastatic renal cell carcinoma (mRCC): efficacy results from the Czech registry (RENIS)

Finek J, Demlova R, Kopeckova K, Buchler T, Melichar B, Prausova J, Poprach A, Hrnciarova T, Mlcoch T, Dolezal T. ESMO 2018 Congress, Munich, Germany. 892P.

Regorafenib in metastatic colorectal cancer: cost-effectiveness analysis based on propensity weighted cohort of Czech Registry

Mlcoch T, Hrnciarova T, Zadak J, Vesela S, Marian M, Dolezal T. Podium presentation, P16 Database studies (DS3). ISPOR 21th Annual European Congress 2018, Barcelona.

Cost-effectiveness analysis of parenteral methotrexate for the treatment of Crohn’s disease in the Czech Republic

Mlcoch T, Hajickova B, Ornstova E, Chadimova K, Bartakova J, Dolezal T. ISPOR 21th Annual European Congress 2018, Barcelona. PGI23.

Availability and reimbursement of orphan drugs in the Czech Republic

Ornstova E, Paris M, Sebestianova M, Mlcoch T, Bartakova J, Chadimova K, Hajickova B, Dolezal T. ISPOR 21th Annual European Congress 2018, Barcelona. PSY147.

Cost-effectiveness analysis of isavuconazole for the treatment of invasive aspergillosis in the Czech Republic

Hajickova B, Mlcoch T, Dolezal T, Charbonneau C, Sung HA, Vothova P, Mazan P, Billova S. ISPOR 21th Annual European Congress 2018, Barcelona. PIN68.

Initiation of the first disease-modifying treatment formultiple sclerosis patients in the Czech Republic – data from the national registry ReMuS

Horakova D, Hrnciarova T, Jircikova J, Dolezal T, Vachova M, Hradilek P, Valis M, Sucha J, Martinkova A, Ampapa R, Gruermelova M, Stetkarova I, Stourac P, Mares J, Dufek M, Kmetova E, Adamkova J, Rockova P. ECTRIMS 2018, Berlin, Germany. P599.

 

2017

A comparison of markov cohort and discrete event simulation models in cost-effectiveness analysis of sorafenib and everolimus in 3rd line metastatic renal-cell carcinoma in the Czech Republic

Mlčoch T, Lamblová K, Ornstová E, Doležal T. ISPOR 20th Annual European Congress 2017, Glasgow. PRS33.

Pharmacoeconomic results of highly innovative drugs approved for temporary reimbursement in the Czech Republic

Ornstová E, Šebestiánová M, Mlčoch T, Lamblová K, Doležal T. ISPOR 20th Annual European Congress 2017, Glasgow. PHP133.

Cost-effectiveness analysis of tacrolimus as primary immunosuppression for lung transplant recipients in the Czech Republic

Lamblová K, Mlčoch T, Ornstová E, Doležal T. ISPOR 20th Annual European Congress 2017, Glasgow. PRM122.

The relationship between biological therapy, work productivity and activity impairment in patients with psoriatic arthritis: prospective multicentre observational sutdy

Mlčoch T, Tužil J, Štolfa J, Šedová L, Jirčíková J, Urbanová M, Doležal T and Pavelka K. ACR Annual Meeting 2017, San Diego.

 

2016

Cost-effectiveness analysis of restricted protein diet in patients with phenylketonuria in the Czech Republic

Mlčoch T, Ševec M, Lamblova K, Mazalová M, Doležal T. ISPOR 19th Annual European Congress 2016, Vienna. PSY83.

Multi-criteria assessment in hta process in the Czech Republic: the role of different stakeholders involvement and potential alternative appraisal of drugs including orphans

Ornstová E, Mlčoch T, Doležalová H, Lamblová K, Mazalová M, Doležal T. ISPOR 19th Annual European Congress 2016, Vienna. PHP3.

Cost-effectiveness analysis of sulodexide in patients with non-prolipherative diabetic retinopathy in the Czech Republic

Lamblova K, Mlčoch T, Mazalová M, Doležal T. ISPOR 19th Annual European Congress 2016, Vienna. PSS39.

 

2015

Cost-effectiveness analysis of the information technology aided relaps prevention programme in schizophrenia (itareps) in the Czech Republic

Mlčoch T, Kruntoradova K, Mandelikova M, Doležal T. ISPOR 18th Annual European Congress 2015, Milano. PMH23.

The impact of anti-tnf (etanercept) therapy on work productivity in patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis in the Czech Republic

Mlčoch T, Jirčíková J, Mandelíkova M, Kruntorádová (Lamblová) K, Doležal T. ISPOR 18th Annual European Congress 2015, Milano. PMS89.

Cost-effectiveness analysis of ginkgo biloba extract (egb 761®) for the treatment of dementia in the Czech Republic

Kruntoradova K, Mandelikova M, Mlčoch T, Doležal T. ISPOR 18th Annual European Congress 2015, Milano. PND47.

 

2014

Cost minimization analysis of activated prothrombin complex concentrate (apcc) compared to recombinant factor viia (rfviia) for hemophilia patients with inhibitors

Mlčoch T, Doležal T, Klimeš J. ISPOR 17th Annual European Congress 2014, Amsterdam. PSY69.

Cost-effectiveness analysis of bendamustin-rituximab compared to chop-rituximab in the treatment of indolent follicular non-hodgkin lymhoma in the Czech Republic

Mlčoch T, Klimeš J, Kruntoradova K, Mandelikova M, Doležal T. ISPOR 17th Annual European Congress 2014, Amsterdam. PCN155.

Long-term quality of life, productivity impairment, disease severity and health care costs in relation to functional impairment in ankylosing spondylitis patients in the Czech Republic

Šedová L, Mlčoch T, Urbanová M, Štolfa J, Suchý D, Smržová A, Klimeš J, Doležal T. ACR Annual Meeting 2014, Boston.

Long-term quality of life, productivity impairment, disease severity and health care costs in relation to functional impairment in psoriatic arthritis patients in the Czech Republic

Štolfa J, Mlčoch T, Šedová L, Suchý D, Klimeš J, Doležal T. CECR 2014, Vienna.

The impact of adherence and development of neutralizing antibodies to interferons β˛ on treatment of multiple sclerosis in the Czech Republic

Kruntoradova K, Klimes J, Dolezal T, Mandelikova M, Pavlikova P. November 2014, ISPOR 17th Annual European Congress, Amsterdam, The Netherlands.

The quality of life following allogeneic hematopoietic stem cell transplantation - the retrospective study of czech transplant centres

Válková V, Jirčíková J, Trnková M, Steinerová K, Keslová P, Lánská M, Kořístek Z, Raida L, Kruntorádová K, Doležal T, Benešová K, Cetkovský P, Trněný M. April 2014, EBMT 2014, 40th Annual Meeting of the European Society for Blood and Marrow Transplantation, Milan, Italy.

 

2013

Factors influencing patient’s quality of life after autologous tranplantation, czech transplatation centres study

Benešová K, Trnková M, Lánská M, Válková V, Steinerová K, Kořístek Z, Novák Jan, Raida L, Keslová P, Vacková B, Kruntorádová K, Doležal T, Trněný M. Czech Transplatation Centres Study. 1382, 9th April 2013, 39th EBMT Annual Meeting, London, UK.

Cost-minimization analysis of multifocal and monofocal intraocular lenses in cataract surgery in the Czech Republic

Kruntorádová K, Klimes J, Doležal T, Vocelka M. PSS31, 5th November 2013, ISPOR 16th Annual European Congress, Dublin, Ireland.

Cost-effectiveness analysis of atorvastatin compared to simvastatin in the prevention of cardiovascular diseases in the Czech Republic

Klimes J, Vocelka M, Doležal T, Kruntorádová K. PCV93, 5th November 2013, ISPOR 16th Annual European Congress, Dublin, Ireland.

 

2012

Work productivity and productivity costs of patients with rheumatoid arthritis, ankylosing spondylitis and psoriasis in the Czech Republic

Kruntorádová K, Klimeš J, Doležal T, Vocelka M, Petříková A. PMS51, 6th November 2012, ISPOR 15th Annual European Congress, Berlin, Germany.

Expenditures and availability of orphan drugs in the Czech Republic: seven year experience (2004 – 2010)

Klimeš J, Doležal T, Vocelka M, Suchánková E, Kruntorádová K. PCN134, 6th November 2012, ISPOR 15th Annual European Congress, Berlin, Germany.

Factors affecting quality of life during and after stem cell transplantation in long term survivors – comparison of autologous and allogeneic stem cell transplantation

Benešová K, Trnková M, Lánská M, Válková V, Steinerová K, Kořístek Z, Novák J, Raida L, Keslová P, Vacková B, Kruntorádová K, Doležal T, and Trněný M. 54163, 8th-11th December 2012, 54th ASH Annual Meeting and Exposition, Atlanta, Georgie, USA.